[ET Net News Agency, 12 December 2019] YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
(01558) said the company entered into a strategic cooperation framework agreement with
Alibaba Health Technology (China) Limited (Alibaba Health (China)).
The company will cooperate with Alibaba Health (China) to carry out influenza special
projects, including assisting the company in optimizing the supply chain management and
enhancing the patient education services by code scanning through the drug tracking
systems in the Ma Shang Fang Xin platform of Alibaba Health (China); promoting influenza
prevention and control knowledge to the public and exploring the brand building of HEC
acknowledged by internet users through the ecosystem of Alibaba Health (China). The term
of cooperation shall be one year.
Alibaba Health (China) is a company whose principal activities include provision of
pharmaceutical e-commerce, medical big data and artificial intelligence, internet
healthcare services, consumer healthcare platform and health management and other
businesses in the PRC. It is an indirect wholly-owned subsidiary of Alibaba Health
Information Technology Limited (00241). (RC)